Ratings for Caribou Biosciences (NASDAQ:CRBU) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Caribou Biosciences, presenting an average target of $21.5, a high estimate of $24.00, and a low estimate of $19.00. A decline of 6.52% from the prior average price target is evident in the current average.
Exploring Analyst Ratings: An In-Depth Overview
A comprehensive examination of how financial experts perceive Caribou Biosciences is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Asthika Goonewardene | Truist Securities | Maintains | Buy | $19.00 | – |
| Robert Burns | HC Wainwright & Co. | Maintains | Buy | $24.00 | – |
| Robert Burns | HC Wainwright & Co. | Raises | Buy | $24.00 | $23.00 |
| Luca Issi | RBC Capital | Maintains | Outperform | $19.00 | – |
Key Insights:
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or ‘Lower’ their stance, it signifies their response to recent developments related to Caribou Biosciences. This offers insight into analysts’ perspectives on the current state of the company.
Rating: Analysts unravel qualitative evaluations for stocks, ranging from ‘Outperform’ to ‘Underperform’. These ratings offer insights into expectations for the relative performance of Caribou Biosciences compared to the broader market.
Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Caribou Biosciences’s future value. Comparing current and prior targets offers insights into analysts’ evolving expectations.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Caribou…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
